Kestra Medical Technologies (KMTS) Return on Equity (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Return on Equity data on file, last reported at 0.01% in Q1 2026.

• Quarterly Return on Equity fell 1.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Jan 2026 was 0.01% (down 1.0% YoY) and the FY2025 annual result came in at 0.53%, changed N/A from the prior year.
• Return on Equity grew to 0.01% in Q1 2026 per KMTS's latest filing, from 0.01% in the prior quarter.
• Across five years, Return on Equity topped out at 0.04% in Q2 2025 and bottomed at 0.01% in Q4 2025.
• The 3-year median for Return on Equity is 0.0% (2025), against an average of 0.0%.
• Peak annual rise in Return on Equity reached 1 bps in 2025, while the deepest fall reached 1 bps in 2025.
• Tracing KMTS's Return on Equity over 3 years: stood at 0.0% in 2024, then slumped by 1792 bps to 0.01% in 2025, then climbed by 15 bps to 0.01% in 2026.
• Per Business Quant, the three latest KMTS Return on Equity figures stand at 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.01% (Q3 2025).

Peer Comparison